Download FREE Sample
The global single-use assemblies market size is expected to grow at a CAGR of 16% over the next five years. Advantages of ready-to-use single-use assemblies, expanding biologics & vaccines manufacturing capacity, growing adoption of flexible and modular production facilities, reduced contamination risk compared to reusable systems, and increasing outsourcing to contract development and manufacturing organizations are some of the key factors driving market growth. To learn more about the research report, download a sample report.
Report Overview
Single-cell analysis is a technique used in biological and medical research to study individual cells at the molecular level. Unlike bulk analysis, which examines large cell populations, single-cell analysis reveals cellular heterogeneity by examining differences in gene expression, protein levels, and metabolic activity. It is crucial for understanding disease mechanisms, identifying rare cell populations, and advancing precision medicine. Technologies such as single-cell RNA sequencing (scRNA-seq), flow cytometry, and mass spectrometry enable high-resolution insights into cellular behavior. Applications span cancer research, immunology, neuroscience, and drug development, making single-cell analysis essential for innovations in diagnostics and targeted therapies. 
Continuous innovations in single-cell analysis techniques to drive market growth
Innovations in single-cell analysis, including NGS, microfluidics, and mass cytometry, drive market growth by enhancing precision, sensitivity, and throughput. These technologies uncover cellular heterogeneity and rare cell populations, improving diagnostics and personalized medicine. Reduced costs and complexity make them more accessible, expanding their use in oncology, immunology, and stem cell research. Growing applications attract investment and collaborations across academia, biotech, and pharma, fueling market expansion. As advancements continue, single-cell analysis accelerates scientific discovery, leading to breakthroughs in disease research and therapeutic development, reinforcing its critical role in the future of biomedical science. 
Rising incidence of cancer and other chronic & infectious diseases to fuel market growth
The rising incidence of cancer and infectious diseases fuels demand for single-cell analysis, enhancing diagnostics and targeted therapies. According to the WHO in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths, and the cancer cases are expected to increase significantly due to aging populations, lifestyle changes, and environmental factors. Single-cell analysis uncovers tumor heterogeneity, identifying resistant cancer subpopulations and improving personalized medicine. It also aids infectious disease research by analyzing host-pathogen interactions, leading to better treatments and vaccines. Increased investment and innovation drive adoption by pharmaceutical, biotech, and academic institutions, expanding the market as precision medicine and advanced research become essential in disease management and therapeutic development.
Competitive Analysis
The global single-cell analysis market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; Merck KGaA; Qiagen; 10x Genomics, Inc.; Standard BioTools Inc.; Promega Corporation; Illumina, Inc.; and Bio-Rad Laboratories, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 2024 |
| Forecast Period | 2025 2030 |
| Growth Rate | 14% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Cell Type, Technique, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Becton, Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; Merck KGaA; Qiagen; 10x Genomics, Inc.; Standard BioTools Inc.; Promega Corporation; Illumina, Inc.; and Bio-Rad Laboratories, Inc. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides thesize of the global single-cell analysis market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, cell type, technique, application, end user.
- Market Size & Forecast (2023-2030), By Product, USD Million
- Consumables
- Beads
- Microplates
- Reagents
- Assay kits
- Immunoassays
- Cell-based assays
- Other Consumables
- Instruments
- Flow Cytometers
- NGS Systems
- PCR Instruments
- Spectrophotometers
- Cell Counters
- Microscopes
- HCS Systems
- Microarrays
- Other Instruments
- Consumables
- Market Size & Forecast (2023-2030), By Cell Type, USD Million
- Human Cell
- Animal Cell
- Microbial Cell
- Market Size & Foreca (2023-2030), By Technique, USD Million
- Flow Cytometry
- Next-generation Sequencing
- Polymerase Chain Reaction
- Microscopy
- Mass Spectrometry
- Others
- Market Size & Forecast (2023-2030), By Application, USD Million
- Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
- Medical Applications
- Non-invasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
- Other Medical Applications
- Research Applications
- Market Size & Forecast (2023-2030), By End User, USD Million
- Biotechnology & Pharmaceutical Companies
- Academic & Research Laboratories
- Hospitals & Diagnostic Laboratories
- Cell banks & IVF Centers
- Other End Users
- Others
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the single-cell analysis market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the single-cell analysis market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
